| 摘要 |
The tautomeric compound d,1-6-oxo-4,5,6,7-tetrahydro-1H- (or 2H)-indazole of the formulae <IMAGE> can be used as an intermediate for preparing tautomeric amino-substituted 4,5,6,7-tetrahydro-1H-(or 2H)- indazoles, or acid addition salts thereof, for use as dopamine agonists when treating Parkinson's disease or for use as prolactin inhibitors.
|
